CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CareDx Inc (CDNA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7150
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

CareDx Inc (CDNA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CareDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CareDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
CareDx Inc, Medical Equipment, Deal Details 11
Venture Financing 11
CareDx Secures USD15 Million in Venture Funding 11
Partnerships 12
CareDx Enters into Licensing and Commercialization Agreement with Illumina 12
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 13
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14
CareDx to Partner with Qiagen 15
CareDx Enters into Co-Development Agreement with Horizon Discovery 16
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17
Equity Offering 18
CareDx Plans to Raise up to USD200 in Public Offering of Securities 18
CareDx Raises USD20 Million in Public Offering of Shares 19
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 21
CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 22
CareDx Raises USD9 Million in Public Offering of Shares 23
CareDx Raises USD8 Million in Private Placement of Units 25
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 26
CareDx Raise USD22 Million in Private Placement of Units 27
CareDx Raises USD14 Million in Private Placement of Units 28
CareDx Raises USD40 Million in IPO 29
Acquisition 31
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 31
CareDx Inc – Key Competitors 32
CareDx Inc – Key Employees 33
CareDx Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Aug 09, 2018: Caredx reports second quarter results 35
May 10, 2018: CareDx Reports First Quarter Results 37
Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 38
Jan 08, 2018: CareDx Reports Preliminary Fourth Quarter and FY2017 Financial Results 40
Nov 09, 2017: CareDx Reports Third Quarter 2017 Financial Results 41
Aug 10, 2017: CareDx Reports Second Quarter 2017 Financial Results 42
Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients 43
Jun 09, 2017: CareDx Reports First Quarter 2017 Financial Results 44
May 22, 2017: CareDx Reports Preliminary First Quarter 2017 Financial Results 45
Apr 21, 2017: CareDx Reports Fourth Quarter and Full Year 2016 Financial Results 46
Mar 15, 2017: CareDx Reports Preliminary Fourth Quarter and FY 2016 Financial Results 47
Corporate Communications 49
Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 49
Apr 21, 2017: CareDx Appoints Michael Bell as Chief Financial Officer 50
Legal and Regulatory 51
Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 51
Product News 52
Oct 02, 2018: CareDx Profiles AlloSeq Suite of NGS Products at ASHI 52
Mar 18, 2018: Olerup QTYPE now available on Applied Biosystems platforms 53
Feb 05, 2018: CareDx Leadership in cfDNA Highlighted at CEoT 54
May 30, 2017: CareDx Activities at European Federation of Immunogenetics Congress 55
Appendix 56
Methodology 56
About GlobalData 56
Contact Us 56
Disclaimer 56

List of Tables
CareDx Inc, Medical Equipment, Key Facts, 2017 2
CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CareDx Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CareDx Inc, Deals By Market, 2012 to YTD 2018 9
CareDx Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
CareDx Secures USD15 Million in Venture Funding 11
CareDx Enters into Licensing and Commercialization Agreement with Illumina 12
Diaxonhit Enters Into Licensing And Distribution Agreement With CareDx (XDx) For AlloMap Molecular Expression Testing 13
CML HealthCare And XDx Enter Into Licensing Agreement For AlloMap Heart Transplant Test 14
CareDx to Partner with Qiagen 15
CareDx Enters into Co-Development Agreement with Horizon Discovery 16
XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 17
CareDx Plans to Raise up to USD200 in Public Offering of Securities 18
CareDx Raises USD20 Million in Public Offering of Shares 19
CareDx Files Registration Statement to Raise Funds through Public Offering of Shares 21
CareDx Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 22
CareDx Raises USD9 Million in Public Offering of Shares 23
CareDx Raises USD8 Million in Private Placement of Units 25
CareDx Plans to Raise up to USD23 Million in Public offering of Shares 26
CareDx Raise USD22 Million in Private Placement of Units 27
CareDx Raises USD14 Million in Private Placement of Units 28
CareDx Raises USD40 Million in IPO 29
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 31
CareDx Inc, Key Competitors 32
CareDx Inc, Key Employees 33
CareDx Inc, Subsidiaries 34

List of Figures
CareDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CareDx Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CareDx Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
CareDx Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
CareDx Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
CareDx Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • InBios International Inc:企業の製品パイプライン分析
    Summary InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal anti …
  • Tractor Supply Co:戦略・SWOT・企業財務分析
    Tractor Supply Co - Strategy, SWOT and Corporate Finance Report Summary Tractor Supply Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AnGes Inc (4563):製薬・医療:M&Aディール及び事業提携情報
    Summary AnGes Inc (AnGes) is a biopharmaceutical company which discovers and develops gene and nucleotide based drugs and reagents for use in functional analysis of genetic medication. The company specializes in research and development (R&D) and practical application of genetic medicine. It has two …
  • Datang International Power Generation Co Ltd:企業の発電所・SWOT分析2018
    Datang International Power Generation Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • CapitaLand Ltd:戦略・SWOT・企業財務分析
    CapitaLand Ltd - Strategy, SWOT and Corporate Finance Report Summary CapitaLand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Western Gas Equity Partners LP:企業の戦略・SWOT・財務情報
    Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report Summary Western Gas Equity Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Fujifilm Corp:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • NVIDIA Corp (NVDA):企業の財務・戦略的SWOT分析
    NVIDIA Corp (NVDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vitamin Shoppe Inc (VSI):企業の財務・戦略的SWOT分析
    Vitamin Shoppe Inc (VSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nordic American Tankers Ltd (NAT):石油・ガス:M&Aディール及び事業提携情報
    Summary Nordic American Tankers Limited (NAT) is a tanker company. It transports crude oil through its fleet of double-hull Suezmax tankers. The company operates its vessels on bareboat charters, time charters, and spot charters. NAT’s tankers are capable of carrying high volumes of oil and able to …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Eftec AG:企業の戦略的SWOT分析
    Eftec AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Olin Corp (OLN):企業の財務・戦略的SWOT分析
    Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Asahi Kasei Pharma Corp:企業の戦略的SWOT分析
    Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Tetra Tech. Inc:企業のM&A・事業提携・投資動向
    Tetra Tech. Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tetra Tech. Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • TransAtlantic Petroleum Ltd (TAT):企業の財務・戦略的SWOT分析
    TransAtlantic Petroleum Ltd (TAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cidara Therapeutics Inc (CDTX):企業の財務・戦略的SWOT分析
    Summary Cidara Therapeutics Inc (Cidara), formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel anti-infectives including immunotherapies. The company's pipeline products include CD101 for treatment of invasive fungal disease; and CD377 for treatin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆